Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

U.S. + International

NanoViricides Inc (NYSE American:NNVC)

Add to Watch List
Set Alert
1.27
Delayed Data
As of Sep 22
 0.00 / 0.00%
Today’s Change
1.03
Today|||52-Week Range
1.71
+18.69%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$80.1M

Company Description

NanoViricides, Inc. is a nano-biopharmaceutical company. The company engages in the discovery, development, and commercialization of therapeutics to advance the care of patients suffering from life-threatening viral infections. It intends to manufacture Injectable and Oral FluCide, HIVCide, Nanoviricide Eye Drops, HerpeCide, DengueCide, RabiCide as well as other drugs for pre-clinical animal studies and human clinical studies. The company was founded by Anil R. Diwan on July 25, 2000 and is headquartered in Shelton, CT.

Contact Information

NanoViricides, Inc.
1 Controls Drive
Shelton Connecticut 06484
P:(203) 937-6137
Investor Relations:

Employees

Shareholders

Individual stakeholders9.67%
Other institutional3.35%
Mutual fund holders2.59%

Top Executives

Anil R. DiwanChairman, President & Secretary
Eugene SeymourChief Executive Officer & Director
Meeta R. VyasChief Financial Officer
Randall W. BartonChief Scientific & Regulatory Officer
Jayant TatakeVice President-Research & Development